BHC (STOCKS)
Bausch Health Companies Inc
$6.510000
+0.170000 (+2.68%)
Prev close: $6.340000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals Other
- CEO
- Thomas J. Appio
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,433.35M
- Employees
- 20,700
- P/E (TTM)
- -2.20
- P/B (TTM)
- -1.37
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
4
Hold
3
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$1.26 | $1.05 | +0.2130 | +20.34% |
|
Mar 2026 (Q1)
|
$0.78 | $0.69 | +0.0856 | +12.33% |
|
Dec 2025 (Q4)
|
$1.10 | $1.28 | -0.1771 | -13.87% |
|
Sep 2025 (Q3)
|
$1.16 | $1.13 | +0.0293 | +2.59% |
Financial Statements
| Revenues | $10.85B |
| Benefits Costs and Expenses | $11.59B |
| Costs And Expenses | $9.97B |
| Operating Expenses | $9.97B |
| Selling, General, and Administrative Expenses | $3.45B |
| Depreciation and Amortization | $1.17B |
| Other Operating Expenses | $5.66B |
| Operating Income/Loss | $883.00M |
| Income/Loss From Continuing Operations After Tax | -$1.09B |
| Income/Loss From Continuing Operations Before Tax | -$732.00M |
| Income Tax Expense/Benefit | $361.00M |
| Net Income/Loss | -$1.09B |
| Net Income/Loss Attributable To Noncontrolling Interest | $5.00M |
| Net Income/Loss Attributable To Parent | -$1.10B |
| Net Income/Loss Available To Common Stockholders, Basic | -$1.10B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.95 |
| Diluted Earnings Per Share | -$2.94 |
| Basic Average Shares | 745,500,000 |
| Diluted Average Shares | 750,300,000 |
| Assets | $24.79B |
| Current Assets | $6.52B |
| Accounts Receivable | $2.26B |
| Inventory | $1.60B |
| Other Current Assets | $2.66B |
| Noncurrent Assets | $18.27B |
| Intangible Assets | $4.18B |
| Other Non-current Assets | $14.09B |
| Liabilities | $25.60B |
| Current Liabilities | $4.54B |
| Accounts Payable | $593.00M |
| Other Current Liabilities | $3.95B |
| Noncurrent Liabilities | $21.05B |
| Long-term Debt | $20.74B |
| Other Non-current Liabilities | $311.00M |
| Equity | -$802.00M |
| Equity Attributable To Noncontrolling Interest | $969.00M |
| Equity Attributable To Parent | -$1.77B |
| Liabilities And Equity | $24.79B |
| Net Cash Flow From Operating Activities | $1.80B |
| Net Cash Flow From Operating Activities, Continuing | $1.80B |
| Net Cash Flow From Investing Activities | -$597.00M |
| Net Cash Flow From Investing Activities, Continuing | -$597.00M |
| Net Cash Flow From Financing Activities | -$1.10B |
| Net Cash Flow From Financing Activities, Continuing | -$1.10B |
| Exchange Gains/Losses | -$5.00M |
| Net Cash Flow | $95.00M |
| Net Cash Flow, Continuing | $100.00M |
| Comprehensive Income/Loss | -$1.12B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $10.00M |
| Comprehensive Income/Loss Attributable To Parent | -$1.13B |
| Other Comprehensive Income/Loss | -$30.00M |